Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb

Bristol Myers Squibb gets USFDA nod for commercial production at newest Devens cell therapy manufacturing facility

Ruchika Sharma11 Jun 2023 11:45 AM IST

Princeton:: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved commercial production at the...

Boehringer Ingelheim, AnGes sign manufacturing agreement for HGF gene therapy product

AstraZeneca, Quell Therapeutics ink pact for engineered T-regulatory cell therapies for autoimmune diseases

Ruchika Sharma11 Jun 2023 10:30 AM IST

Quell will receive USD 85 million upfront from AstraZeneca, which comprises a predominant cash payment and an equity investment.

Kerala CM holds talks with Pfizer over opening of research centre in Kerala

Ruchika Sharma10 Jun 2023 5:04 PM IST

The Pfizer officials also shared their interest in working with the state's new Digital Science Park, inaugurated recently by Prime Minister Narendra...

Zydus gets USFDA nod for bowel disease drug Balsalazide Disodium

Ruchika Sharma10 Jun 2023 3:17 PM IST

The product will be manufactured at the group’s formulation manufacturing facility in SEZ, Ahmedabad, India.

USFDA advisory committee votes unanimously to confirm clinical benefit of Leqembi for Alzheimer's Disease

Ruchika Sharma10 Jun 2023 1:30 PM IST

Tokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System...

Delhi: Medical store owner selling illegal narcotics in Nihal Vihar, arrested

Ruchika Sharma10 Jun 2023 12:30 PM IST

New Delhi: A medical store owner was arrested in connection with the sale and purchase of illegal narcotics in outer Delhi’s Nihal Vihar, officials...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

USFDA accepts application for Merck KEYTRUDA plus chemotherapy as treatment for Biliary Tract Cancer

Ruchika Sharma9 Jun 2023 5:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for review...

Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA

Indoco Remedies Baddi facility bags EU GMP certification from Health Authority of Germany

Ruchika Sharma9 Jun 2023 3:39 PM IST

The EU GMP certification issued by the German Health Authority (Berlin) confirms that the site complies with the Good Manufacturing Practice...

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca-Sanofi Nirsevimab unanimously recommended by USFDA Advisory Committee for prevention of RSV in infants

Ruchika Sharma9 Jun 2023 1:30 PM IST

London: The US Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) has voted unanimously 21 to 0 that AstraZeneca and...

Zydus Lifesciences Told To Revise PMS Study For Tofacitinib ER Tablets

Zydus Lifesciences begins Phase IV trial for fatty liver disease drug Saroglitazar Magnesium

Ruchika Sharma9 Jun 2023 12:30 PM IST

The USFDA has granted Fast Track status and Orphan Drug Designation for Saroglitazar Mg in PBC.

Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to Stelara

Biocon gets EU GMP compliance certificate for Bangalore facility

Ruchika Sharma9 Jun 2023 11:15 AM IST

Bangalore: Biocon Limited has informed in a recent BSE filing that its Active Pharmaceutical Ingredient (API) manufacturing facility located in...

Novartis opens new radioligand therapy manufacturing facility in California

Novartis sees Sandoz adding USD 3 billion in net sales over next five years

Ruchika Sharma8 Jun 2023 4:30 PM IST

London: Novartis' soon-to-be spun off generics division Sandoz is expected to expand its pipeline and potentially generate an additional $3...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok